Skip to main content

Table 1 Patient characteristics (n = 30)

From: Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study

Characteristic No. (%)
Age Median (IQR)
  55.5 (51–65.5)
Gender
 Male 14 (47)
 Female 16 (53)
ECOG Performance Status
 ECOG PS 0 21 (70)
 ECOG PS 1 9 (30)
Tumor localization
 Extrahepatic 6 (20)
 Intrahepatic 17 (57)
 Gallbladder 5 (17)
 Ampulla vateri 2 (7)
Stage TNM
 T1/T2/T3/T4 4 (13)/15 (50)/11 (37)/0 (0)
 N0/1 20 (67)/10 (33)
Margin Status
 R0 28 (93)
 R1 2 (7)
Operative Procedurea
 Major hepatectomy 17 (57)
 Hepatopancreaticoduodenectomy 1 (3)
 Gall bladder bed resection 9 (30)
 Pancreaticoduodenectomy 5 (17)
Time of initiation of Chemotherapy (days) Median (IQR) 49.5 (39.8–64.5)
  1. Abbreviations: IQR Interquartile Range, ECOG Eastern Cooperative Oncology Group, TNM tumor node metastasis, R residual tumor after treatment
  2. aIncludes multiple counts